Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,254,755
+$785,523 QoQ
Shares Held
12,980
-2.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#166
of 422 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026&PARTNERS holds $76,040,383 across 16 Diagnostics & Research names. ICLR ranks #9 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
124,363 | $26,358,737 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
28,690 | $14,384,018 | |
| 3 | DHR |
Danaher Corp /De/
|
58,225 | $11,090,698 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
6,313 | $3,323,415 | |
| 5 | WAT |
Waters Corp /De/
|
8,275 | $3,103,456 | |
| 6 | LH |
Labcorp Holdings Inc.
|
10,611 | $2,971,080 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,309 | $2,764,784 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
4,426 | $2,343,965 |
All Filings in ICLR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,254,755 | 12,980 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,469,232 | 13,277 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,655,468 | 9,085 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,849,400 | 10,568 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,281,414 | 8,810 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $366,254 | 2,093 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $467,863 | 2,231 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $755,337 | 2,629 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $273,659 | 873 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||